Navneet Majhail
@bldcancerdoc.bsky.social
Physician-in-Chief of Blood Cancers, Sarah Cannon Cancer Network | President ASTCT 2019 | #BMTsm #CARTcell #CellTherapy
Pinned
Navneet Majhail
@bldcancerdoc.bsky.social
· Dec 27
We are hiring to add to our 60+ leukemia/cell therapy/BMT physicians across the Sarah Cannon Transplant and Cellular Therapy Network - pls direct message me to learn more about opportunities for clinical investigators and clinicians 🙏
Reposted by Navneet Majhail
I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.
pages.lls.org/ltn/tn/MidTN...
pages.lls.org/ltn/tn/MidTN...
Navneet's Light The Night Fundraiser
Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...
pages.lls.org
October 11, 2025 at 5:08 PM
I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.
pages.lls.org/ltn/tn/MidTN...
pages.lls.org/ltn/tn/MidTN...
I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.
pages.lls.org/ltn/tn/MidTN...
pages.lls.org/ltn/tn/MidTN...
Navneet's Light The Night Fundraiser
Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...
pages.lls.org
October 11, 2025 at 5:08 PM
I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.
pages.lls.org/ltn/tn/MidTN...
pages.lls.org/ltn/tn/MidTN...
It was great to catch up with fellow Cleveland Clinic expat Nate Pennell during his recent visit to Sarah Cannon Research Institute Nashville. Looking forward to his leadership and vision for cancer at BMS.
October 7, 2025 at 3:39 PM
It was great to catch up with fellow Cleveland Clinic expat Nate Pennell during his recent visit to Sarah Cannon Research Institute Nashville. Looking forward to his leadership and vision for cancer at BMS.
Impactful @ascocancer.bsky.social @theaacr.bsky.social session on innovations and access challenges for gene therapy. Dr Frangoul from Sarah Cannon Cancer Network/SCRI shared experience with clinical trials of Exa-cel. Jimi Olaghere shared experience as patient #16 on a trial. #ASCO25
June 1, 2025 at 1:44 PM
Impactful @ascocancer.bsky.social @theaacr.bsky.social session on innovations and access challenges for gene therapy. Dr Frangoul from Sarah Cannon Cancer Network/SCRI shared experience with clinical trials of Exa-cel. Jimi Olaghere shared experience as patient #16 on a trial. #ASCO25
@daxmd.bsky.social presents on multi-cancer early detection at #ASCO25: Highlights positive predictive value & sensitivity of reflex ctDNA methylation MCED for several cancer types in individuals with obesity. With its footprint in 20 states, Sarah Cannon Cancer Network is a pioneer in MCED studies.
June 1, 2025 at 1:37 PM
@daxmd.bsky.social presents on multi-cancer early detection at #ASCO25: Highlights positive predictive value & sensitivity of reflex ctDNA methylation MCED for several cancer types in individuals with obesity. With its footprint in 20 states, Sarah Cannon Cancer Network is a pioneer in MCED studies.
Grateful for Sarah Cannon Research Institute colleagues all over the country who work hard and collaborate to advance cancer therapeutics. Learn more about #SCRI research that is being presented at #ASCO25 #ASCO2025 www.scri.com/asco/
May 30, 2025 at 2:00 PM
Grateful for Sarah Cannon Research Institute colleagues all over the country who work hard and collaborate to advance cancer therapeutics. Learn more about #SCRI research that is being presented at #ASCO25 #ASCO2025 www.scri.com/asco/
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation @bloodadvances.bsky.social
ashpublications.org/bloodadvance...
ashpublications.org/bloodadvance...
May 27, 2025 at 6:33 PM
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation @bloodadvances.bsky.social
ashpublications.org/bloodadvance...
ashpublications.org/bloodadvance...
I am in profound awe of the closeted prostate cancer experts who have emerged on social media over the last 24-48 hrs!
May 20, 2025 at 5:00 AM
I am in profound awe of the closeted prostate cancer experts who have emerged on social media over the last 24-48 hrs!
Hey regular CAR-T 🚗 , armored #CARTcell 🏎️ has entered the room!
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | NEJM
Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment
of B-cell cancers, but many patients do not have long-term remission. We designed
an anti-CD19 enhanced (armore...
www.nejm.org
May 9, 2025 at 12:50 PM
Hey regular CAR-T 🚗 , armored #CARTcell 🏎️ has entered the room!
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....
Reposted by Navneet Majhail
Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4-week-long observership at the @uofcahealth.bsky.social.
📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy
📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy
May 6, 2025 at 5:26 PM
Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4-week-long observership at the @uofcahealth.bsky.social.
📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy
📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy
Congrats to Dr Stephen Strickland from Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville for presenting first-in-human results of SENTI-202 (CD33/FLT3 off-the-shelf CAR NK #celltherapy) in heme malignancies/AML #AACR25
www.aacr.org/about-the-aa...
www.aacr.org/about-the-aa...
Off-the-shelf CAR Natural Killer Cell Therapy with Logic Gates Elicits Complete Remissions in Relapsed or Refractory Blood Cancers
Several patients with AML, who were treated with SENTI-202 experienced a complete remission after not responding to or having relapsed following prior treatments, according to results presented at the...
www.aacr.org
April 28, 2025 at 3:09 AM
Congrats to Dr Stephen Strickland from Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville for presenting first-in-human results of SENTI-202 (CD33/FLT3 off-the-shelf CAR NK #celltherapy) in heme malignancies/AML #AACR25
www.aacr.org/about-the-aa...
www.aacr.org/about-the-aa...
Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies www.nytimes.com/2025/04/27/h...
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.
www.nytimes.com
April 28, 2025 at 2:58 AM
Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies www.nytimes.com/2025/04/27/h...
🙏 for sharing @jameabraham.bsky.social - we share our learnings from Sarah Cannon Transplant and Cellular Therapy Network outpatient #CARTcell program (200+ patients treated in 2024)
Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social
April 19, 2025 at 11:56 PM
🙏 for sharing @jameabraham.bsky.social - we share our learnings from Sarah Cannon Transplant and Cellular Therapy Network outpatient #CARTcell program (200+ patients treated in 2024)
Getting a lot of questions from our immunocompromised transplant/#CARTcell patients about measles vaccination with the recent uptick in outbreaks across the US; Resurfacing 2019 @astct.bsky.social guideline by @pergamic.bsky.social and colleagues www.astctjournal.org/article/S108...
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy
Until recently, measles exposures were relatively rare and so, consequently, were
an afterthought for cancer patients and/or blood and marrow transplant recipients
and their providers. Declines in mea...
www.astctjournal.org
April 15, 2025 at 5:38 PM
Getting a lot of questions from our immunocompromised transplant/#CARTcell patients about measles vaccination with the recent uptick in outbreaks across the US; Resurfacing 2019 @astct.bsky.social guideline by @pergamic.bsky.social and colleagues www.astctjournal.org/article/S108...
Had a great 1 1/2 days with new/emerging transplant and cellular therapy leaders at @astct.bsky.social Leadership Course; future of transplant and cell therapy is strong in the hands of our very talented young physician and administrative leaders
April 12, 2025 at 1:59 AM
Had a great 1 1/2 days with new/emerging transplant and cellular therapy leaders at @astct.bsky.social Leadership Course; future of transplant and cell therapy is strong in the hands of our very talented young physician and administrative leaders
Foundation for the Accreditation of Cellular Therapy is organizing a community #CART working group to facilitate broader utilization of its accreditation standards for cell therapies - important step towards providing high-quality care to patients in the community factglobal.org/education-an...
Press Release
PRESS RELEASE
OMAHA, Neb. - The Foundation for the Accreditation of Cellular Therapy (FACT) is announcing the formation of a ‘Community CAR T Working Group’ (working group) to discuss and propose cl...
factglobal.org
April 11, 2025 at 7:53 PM
Foundation for the Accreditation of Cellular Therapy is organizing a community #CART working group to facilitate broader utilization of its accreditation standards for cell therapies - important step towards providing high-quality care to patients in the community factglobal.org/education-an...
Dr David Johnson reprises 7 dictums for oncologists on what NOT to do for grand rounds:
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice
ascopubs.org
April 7, 2025 at 8:45 PM
Dr David Johnson reprises 7 dictums for oncologists on what NOT to do for grand rounds:
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...
Academic Writing: Who is the Audience and What is the Message? Dr Weisdorf challenges us to consider: Which papers stated something new? Which challenged existing dogma or changed the field? Which were really important over time? @astct.bsky.social www.astctjournal.org/article/S266...
Academic Writing: Who is the Audience and What is the Message?
“The Secret is Comprised in Three Words–Work, Finish, Publish”Michael Faraday
www.astctjournal.org
April 6, 2025 at 3:21 PM
Academic Writing: Who is the Audience and What is the Message? Dr Weisdorf challenges us to consider: Which papers stated something new? Which challenged existing dogma or changed the field? Which were really important over time? @astct.bsky.social www.astctjournal.org/article/S266...
Huge loss for the cell and gene therapy community. Dr Marks had been at the forefront of innovating US’s regulatory framework to ensure access to these transformative therapies.
Our story on Marks’s ouster has been updated with a lot of comment and context www.statnews.com/2025/03/28/f...
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
www.statnews.com
March 29, 2025 at 1:46 PM
Huge loss for the cell and gene therapy community. Dr Marks had been at the forefront of innovating US’s regulatory framework to ensure access to these transformative therapies.
Sarah Cannon Transplant and Cellular Therapy Registry work led by Drs Rao and Battiwalla comparing bendamustine vs. Flu/Cy LD chemo prior to #CART in #Lymphoma. This was done during period of Flu shortage. No difference in OS, PFS, CRS, ICANS.
www.astctjournal.org/article/S266...
www.astctjournal.org/article/S266...
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma
Chimeric antigen receptor T-cell (CAR-T) therapy is a widely adopted treatment for
relapsed/refractory non-Hodgkin lymphomas (NHLs)1. FDA-approved CAR-T products for
large B-cell lymphoma (LBCL) inclu...
www.astctjournal.org
March 24, 2025 at 11:16 PM
Sarah Cannon Transplant and Cellular Therapy Registry work led by Drs Rao and Battiwalla comparing bendamustine vs. Flu/Cy LD chemo prior to #CART in #Lymphoma. This was done during period of Flu shortage. No difference in OS, PFS, CRS, ICANS.
www.astctjournal.org/article/S266...
www.astctjournal.org/article/S266...
Nephrotoxicity in CAR-T cell therapy - Transplantation and Cellular Therapy @astct.bsky.social www.astctjournal.org/article/S266...
Nephrotoxicity in CAR-T cell therapy
Modern immunotherapies revolutionize cancer treatment. Due to advances in molecular
biology, therapies such as immune checkpoint inhibitors, naked, armed, and bispecific
monoclonal antibodies, and chi...
www.astctjournal.org
March 20, 2025 at 12:59 PM
Nephrotoxicity in CAR-T cell therapy - Transplantation and Cellular Therapy @astct.bsky.social www.astctjournal.org/article/S266...
How to do gene therapy for sickle cell disease and thalassemia - from Dr Frangoul et al at our pediatric Sarah Cannon TCT Program at TriStar Centennial in Nashville. #GeneTherapy #SickleCell @astct.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-Thalassemia
Sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) are inherited blood disorders caused by pathogenic variants of the β-globin ge…
www.sciencedirect.com
March 19, 2025 at 2:54 PM
How to do gene therapy for sickle cell disease and thalassemia - from Dr Frangoul et al at our pediatric Sarah Cannon TCT Program at TriStar Centennial in Nashville. #GeneTherapy #SickleCell @astct.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Beer, wine, and transplant. I have always enjoyed these reflections from Dr McCann in Bone Marrow Transplant. www.nature.com/articles/s41...
Guinness 0.0: a miracle! - Bone Marrow Transplantation
Bone Marrow Transplantation - Guinness 0.0: a miracle!
www.nature.com
March 11, 2025 at 12:04 PM
Beer, wine, and transplant. I have always enjoyed these reflections from Dr McCann in Bone Marrow Transplant. www.nature.com/articles/s41...